DEA Sets New Import, Export Restrictions for Methoxetamine

The Drug Enforcement Administration is listing methoxetamine (MXE), a member of the arylcyclohexylamine class of drugs with dissociative anesthetic and hallucinogenic properties, similar to phencyclidine (PCP) and ketamine, under Schedule I of the Controlled Substances Act, it said in a notice published June 6. “This action imposes the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis with, or possess), or propose to handle, methoxetamine.” The listing takes effect July 6.